OptraSCAN
PrivateLast Round
Series B
Nov 5, 2024
Total Funding Raised
$30M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
OptraSCAN operates in Healthcare & Life Sciences and is based in San Jose, California. Its latest recorded funding round was a Series B round in November 2024.
OptraSCAN is a medical equipment manufacturing company that provides digital pathology solutions, including slide scanners, AI-based image analysis, and cloud-based storage.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Telemedicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OptraSCAN Comparables
Compare OptraSCAN with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mikroscan Technologies | 85% | |
| MedPrime Technologies | 79% | |
| Morphle Labs | 79% |
For institutional investors. Book with your work email.
OptraSCAN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 5, 2024 | ||||
| Series A | Oct 18, 2016 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 44% MoM, reaching 5.1K.
- Aug 20, 2026
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 13, 2026
OptraSCAN, Inc. announces plans to unveil the FDA-cleared OS-Ultra whole slide scanner at the Digital Pathology Association's Pathology Visions 2026 conference in California on Oct 16th–18th '26, marking its first public showing since FDA clearance.
- launchesOct 13, 2026
OptraSCAN, Inc. plans to unveil the FDA-cleared OS-Ultra whole slide scanner at Pathology Visions 2026 in San Diego, California, from Oct 16th–18th '26; the scanner makes its first public appearance at booth 417 and is available starting in Dec '26.
For institutional investors. Book with your work email.
OptraSCAN Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OptraSCAN's valuation, stock price, and market status.
Is OptraSCAN a public or private company?
OptraSCAN is a private company.
What is the current stock price of OptraSCAN?
OptraSCAN is a private company, so its shares have no public market price. Caplight tracks OptraSCAN's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OptraSCAN worth (valuation)?
Valuation information for OptraSCAN is not publicly available.
Can I buy OptraSCAN stock?
OptraSCAN shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OptraSCAN's last funding round?
OptraSCAN's most recent funding round was Series B on November 5, 2024.
Who are the main investors in OptraSCAN?
Investor information for OptraSCAN is not publicly disclosed.
Will OptraSCAN IPO soon?
No public IPO plans have been announced for OptraSCAN.
How can I track OptraSCAN secondary market activity?
Caplight tracks bids, offers, and trades in OptraSCAN's shares on secondary markets.